Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017400 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-08 | 2022-03-04 | ADPT | SOOD NITIN | Chief Commercial Off | A - Grant | $0.00 | +65.9K | 163.1K | +68% | $0 |
| D | 2022-03-08 | 2022-03-04 | ADPT | SOOD NITIN | Chief Commercial Off | A - Grant | $0.00 | +164.7K | 164.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | A | A | 65,898 | $0.00 | 163,111 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-04 | A | A | 164,745 | $0.00 | 164,745 | D | $12.14 · — to 2032-03-04 | 164,745 Common Stock | (F1) The options vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |